Predicting the Physiological Effect of Revascularization in Serially Diseased Coronary Arteries.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
02 2019
Historique:
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 26 2 2020
Statut: ppublish

Résumé

Fractional flow reserve (FFR) is commonly used to assess the functional significance of coronary artery disease but is theoretically limited in evaluating individual stenoses in serially diseased vessels. We sought to characterize the accuracy of assessing individual stenoses in serial disease using invasive FFR pullback and the noninvasive equivalent, fractional flow reserve by computed tomography (FFR Patients with angiographic serial coronary artery disease scheduled for PCI were enrolled and underwent prospective coronary CT angiography with conventional FFR FFR pullback and conventional FFR

Sections du résumé

BACKGROUND
Fractional flow reserve (FFR) is commonly used to assess the functional significance of coronary artery disease but is theoretically limited in evaluating individual stenoses in serially diseased vessels. We sought to characterize the accuracy of assessing individual stenoses in serial disease using invasive FFR pullback and the noninvasive equivalent, fractional flow reserve by computed tomography (FFR
METHODS AND RESULTS
Patients with angiographic serial coronary artery disease scheduled for PCI were enrolled and underwent prospective coronary CT angiography with conventional FFR
CONCLUSIONS
FFR pullback and conventional FFR

Identifiants

pubmed: 30722688
doi: 10.1161/CIRCINTERVENTIONS.118.007577
pmc: PMC6794156
mid: EMS84272
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007577

Subventions

Organisme : Department of Health
ID : 10/57/67
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/13/15/30026
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/15/78/31678
Pays : United Kingdom

Références

Circulation. 2010 Nov 23;122(21):e525-55
pubmed: 20975004
JACC Cardiovasc Interv. 2015 Jul;8(8):1018-1027
pubmed: 26205441
J Am Coll Cardiol. 2014 Apr 1;63(12):1145-1155
pubmed: 24486266
Circulation. 2000 Nov 7;102(19):2371-7
pubmed: 11067791
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
N Engl J Med. 1996 Jun 27;334(26):1703-8
pubmed: 8637515
Eur Heart J. 2015 Dec 14;36(47):3359-67
pubmed: 26330417
J Am Coll Cardiol. 2013 Jun 4;61(22):2233-41
pubmed: 23562923
JAMA Cardiol. 2017 Jul 1;2(7):803-810
pubmed: 28538960
N Engl J Med. 2008 Nov 27;359(22):2324-36
pubmed: 19038879
J Am Coll Cardiol. 2008 Nov 18;52(21):1724-32
pubmed: 19007693
JACC Cardiovasc Interv. 2015 Mar;8(3):398-403
pubmed: 25790763
JAMA Cardiol. 2018 May 1;3(5):432-438
pubmed: 29562079
Circulation. 2003 Jun 17;107(23):2900-7
pubmed: 12771008
JACC Cardiovasc Interv. 2014 Dec;7(12):1386-96
pubmed: 25459526
Am J Cardiol. 2000 Dec 1;86(11):1166-70
pubmed: 11090785
Circulation. 1978 Jan;57(1):133-6
pubmed: 618380
N Engl J Med. 2009 Jan 15;360(3):213-24
pubmed: 19144937
J Am Coll Cardiol. 2011 Nov 1;58(19):1989-97
pubmed: 22032711
J Cardiovasc Comput Tomogr. 2017 Nov;11(6):429-436
pubmed: 28789941
JAMA Cardiol. 2018 May 1;3(5):368-370
pubmed: 29562076
N Engl J Med. 2012 Sep 13;367(11):991-1001
pubmed: 22924638

Auteurs

Bhavik N Modi (BN)

NIHR Biomedical Research Centre and British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, King's College London (B.N.M., H.E., R.R., D.P.).

Sethuraman Sankaran (S)

HeartFlow Inc, Redwood City, California (S.S., H.J.K., C.R., C.A.T.).

Hyun Jin Kim (HJ)

HeartFlow Inc, Redwood City, California (S.S., H.J.K., C.R., C.A.T.).

Howard Ellis (H)

NIHR Biomedical Research Centre and British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, King's College London (B.N.M., H.E., R.R., D.P.).

Campbell Rogers (C)

HeartFlow Inc, Redwood City, California (S.S., H.J.K., C.R., C.A.T.).

Charles A Taylor (CA)

HeartFlow Inc, Redwood City, California (S.S., H.J.K., C.R., C.A.T.).

Ronak Rajani (R)

NIHR Biomedical Research Centre and British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, King's College London (B.N.M., H.E., R.R., D.P.).

Divaka Perera (D)

NIHR Biomedical Research Centre and British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, King's College London (B.N.M., H.E., R.R., D.P.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH